HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2- (6- (2- (3,5- dichloro- 4- pyridyl)acetyl)- 2,3- dimethoxyphenoxy)- N- propylacetamide

inhibits phosphodiesterase 4; structure in first source

Also Known As:

LEO 29102

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amides: 2428
  - Acetamides: 21
    - 2-(6-(2-(3,5-dichloro-4-pyridyl)acetyl)-2,3-dimethoxyphenoxy)-N-propylacetamide: 1
- Carboxylic Acids: 973
  - Acyclic Acids
    - Acetates: 4994
      - Acetamides: 21
        2-(6-(2-(3,5-dichloro-4-pyridyl)acetyl)-2,3-dimethoxyphenoxy)-N-propylacetamide: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - 2-(6-(2-(3,5-dichloro-4-pyridyl)acetyl)-2,3-dimethoxyphenoxy)-N-propylacetamide: 1

Experts

1.	Andersson, Christina: 1 article (07/2014)
2.	Engell, Karen: 1 article (07/2014)
3.	Felding, Jakob: 1 article (07/2014)
4.	Hegardt, Pontus: 1 article (07/2014)
5.	Ladefoged, Lotte G: 1 article (07/2014)
6.	Larsen, Jens: 1 article (07/2014)
7.	Nielsen, Simon Feldbæk: 1 article (07/2014)
8.	Poulsen, Tina D: 1 article (07/2014)
9.	Refer, Pia: 1 article (07/2014)
10.	Søhoel, Anders: 1 article (07/2014)

Related Diseases

1.	Atopic Dermatitis (Atopic Eczema) 07/24/2014 - "Discovery and early clinical development of 2-{6-[2-(3,5-dichloro-4-pyridyl)acetyl]-2,3-dimethoxyphenoxy}-N-propylacetamide (LEO 29102), a soft-drug inhibitor of phosphodiesterase 4 for topical treatment of atopic dermatitis."

Related Drugs and Biologics

1.	Type 4 Cyclic Nucleotide Phosphodiesterases